Optic Nerve Diffusion Measurement from Diffusion-Weighted Imaging in Optic Neuritis

References

1. ↵
   Stejskal EO, Tanner JE. Spin diffusion measurements: spin echoes in the presence of a time-dependent field gradient. J Chem Phys 1965;42:288–292

   CrossRef
2. ↵
   Basser PJ, Mattiello J, LeBihan D. MR diffusion tensor spectroscopy and imaging. Biophys J 1994;66:259–267

   CrossRefPubMedWeb of Science
3. ↵
   Filippi M, Inglese M. Overview of diffusion-weighted magnetic resonance studies in multiple sclerosis [Suppl 1]. J Neurol Sci 2001;186:S37–S43
4. ↵
   Werring DJ, Clark CA, Barker GJ, et al. Diffusion tensor imaging of lesions and normal-appearing white matter in multiple sclerosis. Neurology 1999;52:1626–1632

   Abstract/FREE Full Text
5. ↵
   Filippi M, Cercignani M, Inglese M, et al. Diffusion tensor magnetic resonance imaging in multiple sclerosis. Neurology 2001;56:304–311

   Abstract/FREE Full Text
6. ↵
   Roychowdhury S, Maldjian JA, Grossman RI. Multiple sclerosis: comparison of trace apparent diffusion coefficients with MR enhancement pattern of lesions. AJNR Am J Neuroradiol 2000;21:869–874

   Abstract/FREE Full Text
7. ↵
   Ebers GC. Optic neuritis and multiple sclerosis. Arch Neurol 1985;42:702–704

   CrossRefPubMedWeb of Science
8. ↵
   Brusaferri F, Candelise L. Steroids for multiple sclerosis and optic neuritis: a meta-analysis of randomized controlled clinical trials. J Neurol 2000;247:435–442

   CrossRefPubMedWeb of Science
9. ↵
   Halliday AM, McDonald WI, Mushin J. Delayed pattern-evoked responses in optic neuritis in relation to visual acuity. Trans Ophthalmol Soc U K 1973;93:315–324

   PubMed
10. ↵
    Gass A, Moseley IF, Barker GJ, et al. Lesion discrimination in optic neuritis using high-resolution fat- suppressed fast spin-echo MRI. Neuroradiology 1996;38:317–321

    PubMedWeb of Science
11. ↵
    Behan CMH, Hickman SJ, Scolding NJ, et al. Identification of the clinically symptomatic lesion in multiple sclerosis: implications for remyelination therapy [Suppl 3]. Rev Neurol (Paris) 2000;156:S28 ; abstract presented at the 16th Congress of ECTRIMS, Toulouse, France, 2000
12. ↵
    Wheeler-Kingshott CA, Parker GJ, Symms MR, et al. ADC mapping of the human optic nerve: increased resolution, coverage, and reliability with CSF-suppressed ZOOM-EPI. Magn Reson Med 2002;47:24–31

    CrossRefPubMedWeb of Science
13. ↵
    Barker GJ. Technical issues for the study of the optic nerve with MRI [Suppl 1]. J Neurol Sci 2000;172:S13–S16
14. ↵
    Freeman AJ, Ballinger R, Werner M, Guy J. Diffusion weighted EPI of the human optic nerve at 3T. Proc Intl Soc Mag Reson Med 1998;6:1265 ; abstract presented at the 6th Annual Meeting of ISMRM, Sydney, Australia, 1998
15. ↵
    Iwasawa T, Matoba H, Ogi A, et al. Diffusion-weighted imaging of the human optic nerve: a new approach to evaluate optic neuritis in multiple sclerosis. Magn Reson Med 1997;38:484–491

    PubMedWeb of Science
16. ↵
    Hickman SJ, Brex PA, Brierley CMH, et al. Detection of optic nerve atrophy following a single episode of unilateral optic neuritis by MRI using a fat-saturated short-echo fast FLAIR sequence. Neuroradiology 2001;43:123–128

    CrossRefPubMedWeb of Science
17. ↵
    Inglese M, Ghezzi A, Bianchi S, et al. Irreversible disability and tissue loss in multiple sclerosis: a conventional and magnetization transfer magnetic resonance imaging study of the optic nerves. Arch Neurol 2002;59:250–255

    CrossRefPubMedWeb of Science
18. ↵
    Compston DA, Batchelor JR, Earl CJ, McDonald WI. Factors influencing the risk of multiple sclerosis developing in patients with optic neuritis. Brain 1978;101:495–511

    FREE Full Text
19. ↵
    Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227–231

    CrossRefPubMedWeb of Science
20. ↵
    Block W, Pauly J, Kerr A, Nishimura D. Consistent fat suppression with compensated spectral-spatial pulses. Magn Reson Med 1997;38:198–206

    PubMed
21. ↵
    Miller AJ, Joseph PM. The use of power images to perform quantitative analysis on low SNR MRI images. Magn Reson Imaging 1993;11:1051–1056

    CrossRefPubMedWeb of Science
22. ↵
    Parker GJM, Schnabel JA, Symms MR, et al. Nonlinear smoothing for reduction of systematic and random errors in diffusion tensor imaging. J Magn Reson Imaging 2000;11:702–710

    CrossRefPubMedWeb of Science
23. ↵
    Ferris FL III, Kassoff A, Bresnick GH, Bailey I. New visual acuity charts for clinical research. Am J Ophthalmol 1982;94:91–96

    PubMedWeb of Science
24. ↵
    Farnsworth D. The Farnsworth-Munsell 100-hue and dichotomous tests for color vision. J Opt Soc Am 1943;33:568–578

    CrossRef
25. ↵
    Brusa A, Jones SJ, Plant GT. Long-term remyelination after optic neuritis: a 2-year visual evoked potential and psychophysical serial study. Brain 2001;124:468–479

    Abstract/FREE Full Text
26. ↵
    Plummer DL. DispImage: a display and analysis tool for medical images. Rivista Neuroradiol 1992;5:489–495
27. ↵
    Bland JM, Altman DG. Measurement error and correlation coefficients. Br Med J 1996;313:41–42

    FREE Full Text
28. Bland JM, Altman DG. Measurement error proportional to the mean. Br Med J 1996;313:106

    FREE Full Text
29. ↵
    Bland JM, Altman DG. Measurement error. Br Med J 1996;313:744

    FREE Full Text
30. ↵
    Hickman SJ, Kapoor R, Jones SJ, et al. Corticosteroids do not prevent optic nerve atrophy following optic neuritis. J Neurol Neurosurg Psychiatry 2003;74:1139–1141

    FREE Full Text
31. ↵
    Chabert S, Molko N, Cointepas Y, et al. “Functional” diffusion tensor imaging of the optic nerve using a non-CPMG fast spin echo sequence. Proc Intl Soc Mag Reson Med 2002;10:1115 ; abstract presented at the 10th Annual Meeting of ISMRM, Honolulu, 2002
32. ↵
    Wheeler-Kingshott CA, Trip A, Symms MR, et al. In vivo anisotropy and diffusivity of the optic nerve: pilot study. Proc Intl Soc Mag Reson Med 2004;11:2471 ; abstract presented at the 12th Annual Meeting of ISMRM, Kyoto, 2004